DRUG · Unmapped registry intervention
Doxorubicin Hydrochloride Liposome Injection
Find medicine records ·
Find other trials using this name
Clinical trial
A Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection
NCT04460820
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedA Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Bioequivalenceunresolved
Interventions
Sponsors & collaborators
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.lead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04460820 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.